Welcome to our dedicated page for CCC news (Ticker: CCC), a resource for investors and traders seeking the latest updates and insights on CCC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CCC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CCC's position in the market.
Clarivate Plc (NYSE: CCC) announced its financial results for the fourth quarter and full year 2020 will be released before the market opens on February 25, 2021. The press release and earnings supplement will be available on the company’s investor website. A conference call will follow at 8:00 AM Eastern Time on the same day to discuss the results, which can be accessed via webcast or by phone. Replay options will be available shortly after the call.
Clarivate Plc (NYSE:CCC) released a report detailing the dynamics of innovation in the global alcoholic beverage sector. Key findings highlight Mainland China's dominance in trademark applications and innovation, outpacing the rest of the world. Despite pandemic-related declines in on-premise sales, the overall market for alcoholic beverages is projected to grow from $515 billion to $528 billion by year-end 2020, fueled by online sales and a boom in craft drinks. The report emphasizes changing consumer preferences, with craft beer and gin gaining popularity.
Clarivate Plc (NYSE: CCC) announced that Executive Chairman Jerre Stead and CFO Richard Hanks will present at the Barclays Global Technology, Media and Telecommunications Conference on December 9, 2020, at 2:00 PM Eastern Time. A live webcast will be accessible via the Investor Relations section of their website, with a replay available for 30 days afterward. Clarivate focuses on providing information and insights to expedite innovation across science and intellectual property domains.
Clarivate Plc (NYSE:CCC) has launched a new colleague retention program that awards restricted share units (RSUs) based on its Customer Delight survey score. This initiative, which aligns employee rewards with customer satisfaction, aims to enhance employee engagement and retention. The program will provide nearly 5,000 full-time colleagues with a $2,000 RSU grant globally. CEO Jerre Stead emphasized that this strategy connects customer and colleague success, fostering long-term value for both the company and its employees.
Clarivate Plc (NYSE:CCC) has announced its acquisition of South Korean Hanlim IPS Co., enhancing its intellectual property solutions and innovation capabilities. The collaboration will cater to the growing demand for PCT filings in South Korea, which rose by 12.8% from 2018 to 2019. This strategic move aims to provide a comprehensive suite of IP solutions and local customer support tailored for the APAC market. Leadership from both companies expressed confidence that this merger will accelerate innovation and broaden market reach.
Clarivate Plc (NYSE: CCC) has announced its 2021 Adjusted diluted EPS outlook, projecting a range of $0.73 to $0.79. This update follows the company's previous outlook shared on November 10, 2020, during its Virtual Investor Day, where it did not include Adjusted EPS due to ongoing evaluations regarding the tax impact from the CPA Global acquisition.
Clarivate Plc (NYSE:CCC) has joined over 3,962 companies in endorsing the Women's Empowerment Principles (WEPs), which promote gender equality in business practices. This commitment reflects the company's stance on sustainability, corporate responsibility, and innovation. Jerre Stead, Executive Chairman and CEO, emphasized the importance of diversity and inclusion as key to solving complex global challenges. By aligning with WEPs, Clarivate aims to contribute to the United Nations Sustainable Development Goals and collaborate with other stakeholders to empower women.
Clarivate Plc (NYSE:CCC) released the 2020 CMR International Pharmaceutical Clinical Factbook, highlighting significant trends in the Phase II clinical trials. The report shows a 7% increase in clinical trial volume from 2014 to 2019, with Phase II trials having 85% amendments. Notably, the average cost per Phase II trial subject exceeds US$90,000, marking these trials as the most expensive. The findings also indicate that while Asia Pacific and North America initiated similar numbers of trials, patient recruitment predominantly occurs in North America.
Clarivate Plc (NYSE: CCC) announced that its subsidiary, MarkMonitor Information Technology, is now a licensed domain name registrar in Mainland China. This enables MarkMonitor to offer multiple top-level domains (TLDs) like .com and .net, facilitating companies' entry into the significant Chinese online market. With over one billion internet users, this expansion supports Clarivate's mission to enhance its intellectual property solutions in a rapidly growing region. The initiative aims to help companies manage domain portfolios while mitigating security risks associated with domain management.
Clarivate Plc (NYSE:CCC) releases its 2020 Highly Cited Researchers list, recognizing 6,167 influential researchers globally. The US leads with 2,650 researchers (41.5%), although its share has decreased from 44% in 2019. Mainland China increases its representation to 770 researchers (12.1%), boosted by institutions like Tsinghua University. The list also features 26 Nobel laureates and 66 Citation Laureates. Notably, Europe and Australia show growth in their contributions to highly cited research, indicating a shift in global research dynamics.
